Read all posts for ‘TRIPs’

This article was written by Faisal I. Chaudhry | University of Pennsylvania  Abstract: Issues surrounding patent protection for pharmaceuticals and access to essential medicines have long been a source of controversy in the context of multilateral trade agreements. Even as the battles that crystallized over anti-retroviral therapies for HIV/AIDS treatment and […]

Research suggests that trade-related aspects of intellectual property rights, when specifically applied to “traditional” or indigenous knowledge, genetic material and plant and animal life, have a detrimental effect on biodiversity. The 2001 Doha Declaration suggested that the TRIPS Council look at the “patent-ability or non patent-ability of plant and animal […]